Form D · Private Equity Fund

Curative Ventures V LLC

Dallas, TX · CIK 0001754072

Offering snapshot reported Mar 26, 2021 · SEC filing

Reported sold: $74M
Investors reported: 23
Minimum accepted: $0
First sale: Sep 10, 2018

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$8,200,000 → $74,000,000
Reported investors8 → 23

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 26, 2021	Amendment	$74,000,000	$65,800,000vs Sep 25, 2018	23	SEC filing
Sep 25, 2018	Initial	$8,200,000	No comparison	8	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.1
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-322153

Source: Form D, filed Mar 26, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

CURATIVE VENTURES V LLC

Investment adviser: CURATIVE VENTURES MANAGEMENT LLC

Gross asset value: $21.1M
Beneficial owners: 23
ADV minimum commitment: $0

Reported in Form ADV on Mar 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator APEX FUND AND CORPORATE SERVICES TEXAS LTD DALLAS, Texas, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor BVWD, LLP DALLAS, Texas, United States

Custodian UBS FINANCIAL SERVICES INC. NEW YORK, New York, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

UBS FINANCIAL SERVICES INC.
SEC 8-16267

Filing source

Form ADV 2059772 · Mar 30, 2026 · Schedule D 7.B.(1), fund 805-1641661692

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
Curative Ventures V LLC (this fund)	Mar 26, 2021	$74,000,000	23
Curative Ventures VI LLC	Feb 27, 2019	$3,400,000	5

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
[Entity] Cv Immetacyte Manager Lp	Executive
N/A Cv Immetacyte Manager Lp	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

3963 Maple Avenue Suite 390
Dallas, TX, 75219